dr. howard a. burris on everolimus: the impact, the toxicity and the nurses
Published 12 years ago • 206 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
1:17
dr. howard a. burris on the potential of t-dm1 in breast cancer
-
0:57
dr. howard burris discusses the mtor inhibitor everolimus for breast cancer
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
0:57
dr. burris on the impact of the asco annual meeting
-
1:39
dr. burris discusses targeting the mtor pathway
-
1:08
dr. howard a. “skip” burris, iii, on modern chemotherapy for patients with her2 breast cancer
-
49:27
dr. ruth patrick on crawford h. greenwalt
-
59:05
regulation of growth by the mtor pathway
-
1:02:01
quieting the estrogen receptor for therapeutic benefit in er breast cancer
-
2:06
dr. burris on recent advances in tnbc
-
0:21
the role of environmental factors in autoimmunity with dr. aristo vojdani
-
2:35
dr. burris on updated monaleesa-2 trial results for hr breast cancer
-
1:31
dr. howard burris on patient-reported outcomes of marianne
-
0:30
dr. howard a. burris gives advice to recent giants of cancer care winners
-
4:31
dr howard a. "skip" burris
-
0:26
dr. howard a. burris reflects on being a 2014 giant of cancer care
-
0:52
dr. burris on predictive biomarkers for chemoimmunotherapy in tnbc
-
0:58
dr. burris on investigational approaches in tnbc
-
1:36
dr. burris discusses the stratification of clinical trials
-
1:22
howard a. "skip" burris iii, md, facp, fasco, comments on the tailorx study from asco 2018
-
1:40
dr. burris on remaining challenges in treating her2 breast cancer
-
1:03
dr. carey on everolimus in metastatic breast cancer